The source register
Keep the original record nearby.
These documents explain particular products, advertised services and professional questions. They do not verify a personal assessment, pharmacy transaction or exchange of information between clinicians.
Provider marketing; public service and product claims · Checked 2026-09-27
CoreAge Rx: Tirzepatide Microdosing Therapy
Read the original documentArticles citing this source
- CoreAge Rx tirzepatide microdose review: the people behind the proposed care
- Tirzepatide microdose care pathways: compare responsibilities before promises
- A smaller-dose promise still needs a specific risk discussion
- Different GLP-1 product names can belong in the same medication review
- A tirzepatide delivery needs a product record, not just tracking
Provider marketing and public terms; direct HTML supplements extraction · Checked 2026-09-27
CoreAge Rx: shared microdose offer and footer
Read the original documentArticles citing this source
Regulatory explanation · Checked 2026-09-27
FDA: Compounding and the FDA, Questions and Answers
Read the original documentArticles citing this source
- CoreAge Rx tirzepatide microdose review: the people behind the proposed care
- Tirzepatide microdose care pathways: compare responsibilities before promises
- Ivím tirzepatide review: where advertised support ends and responsibilities begin
- Noom tirzepatide clinical-support review: doctor chat, coaching and account help
- A smaller-dose promise still needs a specific risk discussion
- Tirzepatide and oral medicines: who reviews the full picture?
- Different GLP-1 product names can belong in the same medication review
- A tirzepatide delivery needs a product record, not just tracking
Exact approved-product label · Checked 2026-09-27
Zepbound prescribing information, revised August 2026
Read the original documentArticles citing this source
- CoreAge Rx tirzepatide microdose review: the people behind the proposed care
- Tirzepatide microdose care pathways: compare responsibilities before promises
- Ivím tirzepatide review: where advertised support ends and responsibilities begin
- Noom tirzepatide clinical-support review: doctor chat, coaching and account help
- A smaller-dose promise still needs a specific risk discussion
- Tirzepatide and oral medicines: who reviews the full picture?
- Different GLP-1 product names can belong in the same medication review
- A tirzepatide delivery needs a product record, not just tracking
Exact approved-product label · Checked 2026-09-27
Mounjaro prescribing information, revised August 2026
Read the original documentArticles citing this source
Provider program, price and service claims · Checked 2026-09-27
Ivím: GLP-1 Microdosing
Read the original documentArticles citing this source
Provider access and care-termination terms · Checked 2026-09-27
Ivím Membership Agreement
Read the original documentArticles citing this source
Provider contract and care-boundary terms · Checked 2026-09-27
Ivím Terms and Conditions, effective May 27, 2026
Read the original documentArticles citing this source
Exact provider program FAQ · Checked 2026-09-27
Noom Microdose GLP-1Rx Plus Program
Read the original documentArticles citing this source
Provider platform and independent clinical-partner terms · Checked 2026-09-27
Noom Terms and Conditions of Use, including Noom Med Section 16
Read the original documentArticles citing this source
Provider medication-included messaging information; usual response claim not tested · Checked 2026-09-27
Noom: Contacting Your Clinician
Read the original documentArticles citing this source
Provider general account-support description · Checked 2026-09-27
Noom: How to Contact Support
Read the original documentArticles citing this source
Dated provider pricing article; named-program entry used · Checked 2026-09-27
Noom Program Cost in 2026, updated September 22, 2026
Read the original documentArticles citing this source
Provider program-specific refund conditions · Checked 2026-09-27
Noom Refund Policy
Read the original documentArticles citing this source
Regulator pharmacy-record and professional-contact guidance · Checked 2026-09-27
FDA: Locate a State-Licensed Online Pharmacy
Read the original documentArticles citing this source
Current regulatory safety and shipping concerns · Checked 2026-09-27
FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Read the original documentArticles citing this source
General medication-coordination guidance, not a tirzepatide-specific interaction study · Checked 2026-09-27